Conduction disturbances remain a leading complication after transcatheter aortic valve replacement, often necessitating permanent pacemaker implantation. Beyond clinical and electrocardiographic risk factors, the anatomic substrate traversed by the conduction system is increasingly measurable on cardiac computed tomography. Interventricular septal thickness directly adjacent to the membranous septum and left ventricular outflow tract may modulate vulnerability to mechanical or inflammatory injury during valve deployment.

Recent work evaluated whether lower interventricular septal thickness on preprocedural CT predicts pacemaker requirement after TAVR, independent of baseline rhythm and device factors. Here we examine the clinical context, measurement approach, and analytic framework, summarize the principal association, and consider how these findings could be integrated into pre-TAVR risk stratification and patient counseling. For source details, see the PubMed record (40983185).

In this article

Imaging-derived septal metrics and conduction risk after TAVR

Permanent pacing after TAVR reflects injury or edema affecting the His-Purkinje axis, commonly manifesting as new left bundle branch block or high-grade atrioventricular block. Mechanical compression from the stent frame, postdilation forces, and local inflammation are implicated. The anatomical relationship between the deployment zone and the conduction tissue is intimate, particularly where the membranous septum tapers into the muscular septum just beneath the aortic annulus. It is biologically plausible that thinner septal myocardium provides less buffer against device-related insult, increasing susceptibility to conduction system impairment. This physiologic rationale has motivated careful measurement of septal thickness on preprocedural CT to refine risk estimates.

Background: conduction injury after TAVR

Despite advances in valve design and implantation techniques, conduction disturbances remain frequent after TAVR and carry implications for recovery, length of stay, and long-term remodeling. Rates of new conduction disease vary by valve type, implantation depth, and patient anatomy. When permanent pacing is required, clinicians must weigh timing, observation protocols, and thresholds for implantation. Across centers, practice varies, reflecting heterogeneity in risk and uncertainty in prediction. A validated, objective preprocedural marker that captures anatomic vulnerability could harmonize decisions and reduce practice variation.

Why septal thickness might matter

The membranous septum is a thin structure, and the His bundle traverses its inferior aspect before entering the muscular septum. A lower thickness of the adjacent interventricular septum may indicate a shorter distance between the valve frame and conduction tissue. In that scenario, similar implantation depths could yield greater conductive pathway compression compared with patients who have a thick muscular buffer. Additionally, thinner septum may be more prone to edema or microinjury during postdilation, further elevating risk. These relationships are detectable on modern CT, where spatial resolution and multiplanar reformatting enable consistent measurements aligned to the outflow tract.

CT acquisition and measurement considerations

Reliable septal measurement requires standardized image acquisition and reconstruction. Electrocardiographically gated contrast-enhanced scans with thin-slice reconstructions minimize motion artifacts at the annular and subannular levels. Multi-planar reformatting along the valve plane and left ventricular outflow tract helps identify the narrowest septal segment adjacent to the membranous portion. Experienced readers define a reproducible reference level, often a fixed distance below the annulus, to reduce variability. Interobserver reproducibility should be quantified, because subtle angulation can change local thickness estimates by a few tenths of a millimeter, which may be clinically meaningful.

From measurement to model: how CT informs pacemaker prediction

The analysis linked lower septal thickness on preprocedural CT to subsequent need for pacemaker after TAVR, with adjustment for baseline conduction and procedural factors. The principal result was that thinner septum was independently associated with pacemaker implantation, supporting a mechanistic connection between device position, tissue buffer, and conduction vulnerability. Notably, the association held when accounting for variables typically implicated in pacing risk, such as valve platform and implantation depth. This suggests that septal thickness contributes unique signal beyond existing predictors and could be incorporated into preprocedural planning algorithms. The PubMed summary is available here: https://pubmed.ncbi.nlm.nih.gov/40983185/.

Feature definition and reproducibility

In imaging analytics, clear feature definition is pivotal. Septal thickness must be measured at a consistent anatomic level, typically orthogonal to the left ventricular outflow tract and aligned with the nadir of the right coronary cusp where the membranous septum is closest. Readers should predefine windowing, slice thickness, and interpolation rules to maintain consistency. Reporting intra- and interobserver agreement, for example with intraclass correlation coefficients and Bland-Altman limits, contextualizes the stability of the metric. Such reproducibility data are necessary before moving from association to clinical implementation.

Model specification and performance

Prediction modeling for pacemaker risk often starts with clinical and electrocardiographic covariates, including preexisting right bundle branch block, PR and QRS prolongation, and procedural details such as valve type and implantation depth. Adding CT-derived septal thickness should be tested for incremental discrimination, calibration, and reclassification. If the analysis used logistic regression, the adjusted odds ratio for thickness would illustrate directionality and magnitude, while shrinkage methods would mitigate overfitting. If more flexible approaches like machine learning were explored, cross-validation and feature importance profiles would be informative. Reporting net benefit across threshold probabilities clarifies clinical utility in decision curves.

Sensitivity analyses and thresholding

Because small measurement differences can influence risk classification, sensitivity analyses around measurement level and cardiac phase are valuable. Assessing whether the association persists across valve platforms and implantation depths strengthens generalizability. Thresholding strategies, such as identifying a septal thickness cutpoint to flag high risk, must balance sensitivity and specificity given potential downstream consequences of altered implantation strategy or prolonged monitoring. Continuous modeling often preserves information and avoids unstable cutoffs, but practical risk tools sometimes require binary rules. Transparent reporting of how thresholds were selected and how robust they are across subgroups is essential for adoption.

How this complements existing predictors

Existing predictors of pacing after TAVR include baseline right bundle branch block, prolonged PR interval, deeper valve implantation, and heavy subannular calcification. CT-derived septal thickness captures a distinct anatomic dimension not fully represented by these factors. Together, anatomical and electrophysiologic markers can build a more complete portrait of vulnerability. For example, a patient with borderline conduction parameters but very thin septum may merit closer monitoring or a deployment strategy that prioritizes higher implantation. Conversely, a relatively thick septum could temper concerns in a borderline candidate. Integrating multiple modest predictors can yield clinically meaningful stratification.

Clinical translation, caveats, and next questions

Applying imaging-derived risk markers in practice requires operational clarity and recognition of local workflows. Preprocedural CT is ubiquitous in TAVR pathways, so incremental postprocessing to measure septal thickness is feasible. Reading protocols should specify the plane and location to avoid drift, and results must be communicated in a standardized report. Multidisciplinary teams can incorporate the measurement into case conferences to guide valve choice and target deployment depth. Importantly, any change in procedural strategy should be prospectively evaluated to ensure that benefits outweigh risks, such as paravalvular leak if depth is constrained by anatomy.

Practical steps for pre-TAVR planning

Teams can pilot a simple workflow that adds septal thickness to the pre-TAVR report alongside annular dimensions, coronary heights, and leaflet calcification. Cardiologists and imaging specialists should agree on a measurement protocol and quality checks. Proceduralists might use this metric to modulate implantation depth, decide on pre- or postdilation strategies, or tailor observation protocols after deployment. For patients flagged at elevated pacing risk, extended telemetry or temporary pacing lead management strategies can be anticipated. Documenting how the measurement influenced decisions will help evaluate impact and refine practice.

Implications for patient counseling

Patients value individualized risk estimates for outcomes that affect recovery and quality of life. Knowing that anatomical features on CT, such as thinner septal thickness, may increase the likelihood of permanent pacing enables more precise counseling. Clinicians can explain that the conduction system sits near the valve and that the tissue buffer varies across individuals. When the buffer is small, the risk of conduction issues is higher, even if every effort is made to minimize trauma. Such discussions can set expectations about monitoring and the possibility of a pacemaker without creating undue alarm.

Limitations and sources of bias

Observational analyses are vulnerable to confounding and selection bias. Referral patterns for TAVR, device choice, and procedural technique may correlate with anatomy, complicating causal interpretation. Measurement error can attenuate associations, especially when the true effect is modest. Additionally, single-center protocols for CT acquisition and analysis may limit generalizability. External validation across diverse platforms and operators is necessary before broad adoption. Finally, the clinical effect of acting on this metric remains to be proven; identifying risk is not the same as preventing the outcome.

Future directions

Next steps include prospectively embedding septal thickness into multiparameter risk tools that also consider membranous septum length, valve oversizing, and implantation depth. Multi-center studies with harmonized CT protocols can assess reproducibility and calibrate risk across scanners and vendors. Pragmatic trials or stepped-wedge implementations could test whether strategy modifications based on septal thickness reduce pacemaker rates without compromising other outcomes. Integration into structured reports and automation with image analysis may streamline clinical use. As the field evolves, CT-derived anatomy will likely play a growing role in personalized TAVR planning for aortic stenosis within the broader domain of structural heart disease.

In summary, preprocedural CT measurement of interventricular septal thickness offers a mechanistically plausible and operationally accessible marker of conduction vulnerability after TAVR. The reported association between lower thickness and subsequent pacemaker implantation, as summarized on PubMed, adds incremental information to established clinical and procedural predictors. Adoption will depend on standardized measurement, validation across settings, and demonstration that acting on the metric improves patient outcomes. Until then, incorporating septal thickness into multidisciplinary deliberations appears reasonable, with careful documentation of decisions and results to inform continuous learning.

LSF-6703007028 | October 2025


How to cite this article

Team E. Cardiac ct septal thickness predicts pacemaker after tavr. The Life Science Feed. Published November 11, 2025. Updated November 11, 2025. Accessed December 6, 2025. .

Copyright and license

© 2025 The Life Science Feed. All rights reserved. Unless otherwise indicated, all content is the property of The Life Science Feed and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission.

References
  1. Lower interventricular septal thickness from computed tomography predicts the need for pacemaker implantation after TAVR. 2024. https://pubmed.ncbi.nlm.nih.gov/40983185/.